§  3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens §  Finalizing contracts with two Long COVID clinics to recruit...
New York, NY, and Tel Aviv, ISRAEL , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...
New York, NY, and Tel Aviv, ISRAEL, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...
RTHM collaborating on Tollovidâ„¢ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function...
§  Lesion swab (standard of care) and saliva-based sample collection planned §  Peer-reviewed publication demonstrating saliva testing sensitivity...
New York, NY, and Tel Aviv, ISRAEL, Aug. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...
NEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...
New York, NY, and Tel Aviv, ISRAEL, July 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...
§  Biomarker data correlates with clinical data announced in January 2022 §  46 patient open label extension being opened to support US FDA EUA...
83% of Respondents With Acute COVID Were Satisfied 68% of Respondents With Long COVID Were Satisfied NEW YORK, NY, and TEL AVIV, ISRAEL, June 23,...